HT
GNCA

HAP Trading’s Genocea Biosciences, Inc. GNCA Stock Holding History

HAP Trading’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12,700
Closed -$3K – 3050
2021
Q3 		$3K Sell
12,700
-4,400
-26% -$8.65K ﹤0.01% 2286
2021
Q2 		$4K Buy
17,100
+5,800
+51% +$14K ﹤0.01% 2209
2021
Q1 		$6K Buy
+11,300
New +$33.5K ﹤0.01% 1743
2020
Q4 		– Sell
-17,600
Closed -$3K – 2522
2020
Q3 		$3K Buy
+17,600
New +$46.2K ﹤0.01% 1499

Other funds holding GNCA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return